The Football Players Health Study at Harvard University invites stakeholders in the health of NFL players to discuss the urgent challenges facing this community and their families.
February 5, 2026
8:30am-1:30pm PST
Presidio Officers’ Club
Ortega Ballroom
50 Moraga Ave.
San Francisco, CA 94129
John Farquhar is CEO of HeartFlow and they are a public for profit company.
Adam Tenforde receives research support and is the co-principal investigator for the Football Players Health Study at Harvard and performs research supported by American Medical Society for Sports Medicine (bone density research), Uniform Health Service (Achilles), and MTEC/Department of Defense (bone stress injuries with shockwave). He is an unpaid medical advisor for NFL Alumni Health. He is a paid consultant for State Farm Insurance, and consultant for Strava, Elev8, and LiteSport. He receives industry support from Enovis, Sanuwave and Storz for equipment use for research studies on treatment of tendinopathy, knee osteoarthritis and bone stress injuries.
Allan Mishra is the founder of VyVerse.com, receives royalties from Blue Engine Biologics IP, and serves on the editorial board of Biologic Orthopedics.Jim Kovach serves as an advisor to HeartFlow Inc. and as an advisor to NFL Alumni Health. He has also worked collaboratively with the Football Player’s Health Study at Harvard University.
Ross Zafonte serves on the scientific advisory board of Myomo, and onecare.ai, evaluates patients in the Massachusetts General Hospital Brain and Body–TRUST Programme, which is funded by the NFL Players Association and receives grants from the NIH.
Herman Taylor receives grant funding from the NFLPA, and serves as an advisor and consultant for Apple, Google, and Microsoft.